Bone turnover markers: understanding their value in clinical trials and clinical practice.
about
PINP as a biological response marker during teriparatide treatment for osteoporosisPostmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspectiveBone mass and biochemical markers of bone turnover in children and adolescents with chronic immune thrombocytopenia: relation to corticosteroid therapy and vitamin D receptor gene polymorphisms.The assessment of fracture risk.Congenital Hypothyroidism and Bone Remodeling Cycle.Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.Bone mineral density in residents of care facilities for the aged and effect of pharmacotherapy."Vitamin D supplementation and bone health in adults with diabetic nephropathy: the protocol for a randomized controlled trial"Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseasesDenosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancerBiomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.Assessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).Socioeconomic status, race, and bone turnover in the Midlife in the US Study.Chronic kidney disease and the skeleton.Management of severe osteoporosis.Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)Is bone equally responsive to calcium and vitamin D intake from food vs. supplements? Use of (41)calcium tracer kinetic model.Serum Osteocalcin as a Diagnostic Biomarker for Primary Osteoporosis in Women.Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial.The association of serum osteocalcin with the bone mineral density in post menopausal women.Growth hormone is positively associated with surrogate markers of bone turnover during puberty.High vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model.Effect of short-term upper-body resistance training on muscular strength, bone metabolic markers, and BMD in premenopausal women.Continuous antiretroviral therapy decreases bone mineral density.Long-term therapy in COPD: any evidence of adverse effect on bone?Ascorbic acid insufficiency induces the severe defect on bone formation via the down-regulation of osteocalcin production.Age-related bone turnover markers and osteoporotic risk in native Chinese womenClinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.Fruit and vegetable intake and bone health in women aged 45 years and over: a systematic review.Biochemical markers of bone turnover - uses and limitations.A meta-analysis of reference markers of bone turnover for prediction of fracture.Bone Turnover with Venlafaxine Treatment in Older Adults with Depression.Biomarkers of Calcific Aortic Valve Disease.Effect of age and sex on bone markers in Chlorocebus aethiops raised in captivity.Rest-activity patterns and falls and fractures in older men.Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease.Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide.Goal-directed treatment of osteoporosis.Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China.
P2860
Q26859267-D0E463F2-9E5F-464E-9BF2-D44D338C4893Q26864207-89F3FB60-51C7-4033-B351-DF204EDC6630Q33401642-A3894549-EAD5-4BDF-B542-441340FB2059Q33685092-D54F4AF0-EED3-4DF0-9CD0-FE633EB55585Q33776007-916F7EAC-B2A4-4D00-8823-9D4ACAD6A7D5Q33789841-71698877-9CA8-4BC3-96D1-12218D989BA8Q33900986-1CBD6F76-7073-4A0F-8F55-ADA3CCF8EED7Q33948822-D568D799-CA5F-40B3-95FC-44CAC0066110Q34096956-39039DD4-A236-4BB3-B00B-D723B079B473Q34597741-EA7FCEFB-5BF8-45FF-9072-0B0B35ACD00DQ35569309-0B4CBDB8-DB3C-4075-B89A-BD4FAEBD6AC4Q35570893-FE1657ED-17AE-46FA-A560-3DB7C9D05FCEQ35644141-7D9972D7-0F86-4958-A58A-8458C9DB980FQ35670217-C1C72BD1-19E4-4FA2-B8D5-9D957103CF73Q35755179-C60DAC2C-7201-484D-900E-4F541861094BQ35852252-59EDDCE6-392F-46F6-A719-673234A770A3Q35884204-93CEAB30-7506-48AF-BF6D-D35226AD22F1Q36067391-3C87B4D6-4BB4-4907-9BC8-9831616CA552Q36077486-8AD6AFE0-0367-4970-8D92-3D2F5B143675Q36807324-363DDED5-969B-4859-808B-6F505601698EQ36924837-F04105BA-9336-49C2-BB99-E652EE59FB7DQ37044192-30221858-43BB-4BC3-B0DE-FBECD26C56C9Q37051561-F10A6D06-D804-48D0-8813-A384875913B2Q37194579-7BE38532-9973-42C9-9DEF-50B333797B87Q37357149-151C2B38-2203-4E32-B0CA-D564A9830693Q37408472-35E257F6-F3AC-4A3C-BFDF-CD696D2909CAQ37420301-D0701AEE-5DEF-4D99-A7AD-87AD7217CC03Q37681874-F79C6F28-53C0-4107-9265-471ED640A711Q37731292-D2C6FD09-CF5D-4535-B7E9-00B6C8FDE8B9Q37821789-45A8DEA9-6395-4EA8-8E91-6C6F1A1B9E63Q38176560-F1972D0A-9DFB-4804-9E8C-C083AD2FE365Q38192911-39368754-6549-4BB0-AD7D-D0DCEC022F02Q38757643-C93C80CB-3526-413E-9D67-5DB5BFB19BE0Q38762609-A505F2A9-7F52-49DF-950F-637DC1F603C7Q40336275-A1FC350A-9BF1-4A45-845C-DC9836D26F7AQ40408507-62674579-C09A-4E8E-8F1B-2C9C29411865Q43820704-F5849FCF-DFE7-4E3D-8C10-B8E509109985Q44386173-541CB3CC-281D-4AAE-9731-629EB1A83BF6Q44874767-3AA0FBA2-BF85-4EBF-97F6-7820FF410189Q45155246-A0F0A860-92DB-4F2F-964B-EB10781916B1
P2860
Bone turnover markers: understanding their value in clinical trials and clinical practice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone turnover markers: underst ...... trials and clinical practice.
@en
Bone turnover markers: underst ...... trials and clinical practice.
@nl
type
label
Bone turnover markers: underst ...... trials and clinical practice.
@en
Bone turnover markers: underst ...... trials and clinical practice.
@nl
prefLabel
Bone turnover markers: underst ...... trials and clinical practice.
@en
Bone turnover markers: underst ...... trials and clinical practice.
@nl
P2860
P1476
Bone turnover markers: underst ...... trials and clinical practice.
@en
P2093
R Armamento-Villareal
P2860
P2888
P304
P356
10.1007/S00198-009-0838-9
P407
P577
2009-02-04T00:00:00Z